Transaction in Own Shares

21st Oct 2024 17:36

RNS Number : 0205J
Tate & Lyle PLC
21 October 2024
 

Transactions in Own Securities

 

21 October 2024

Tate & Lyle plc (the "Company") announces that it has purchased the following number of its ordinary shares from Merrill Lynch International ("BofA") as part of its share buyback programme announced on 20 June 2024 (the "Programme").

Date of purchase:

21 October 2024

Number of ordinary shares of £0.2916666667 each purchased:

378,645

Highest price paid per share (£):

7.86

Lowest price paid per share (£) :

7.69

Volume weighted average price paid per share (£):

7.75

The repurchased shares will be held in treasury. Following the purchase of these shares, the Company holds 19,360,222 of its ordinary shares in treasury and has 382,362,511 ordinary shares in issue (excluding treasury shares).

Aggregated Information

 

Date

Trading venue

Volume weighted average price (£ per share)

Number of Shares Purchased

 

21 October 2024

London Stock Exchange

7.74

290,047

21 October 2024

Chi-X (CXE)

7.76

56,065

21 October 2024

BATS (BXE)

7.75

32,533

Transaction Details

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by BofA on behalf of the Company as part of the Programme is detailed on the attached:

http://www.rns-pdf.londonstockexchange.com/rns/0205J_1-2024-10-21.pdf

 

The LEI reference for Tate & Lyle PLC is 2138008K14474WPKZ244.

For further information please contact:

Christopher Marsh, VP, Investor Relations

Mobile: +44 (0)7796 192 688

Nick Hasell (FTI Consulting), Media Relations

Mobile: +44 (0)7825 523 383

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMBBFTMTJTBII